Skip to main content

Table 2 Self-reported practices of primary-care physicians in the management of H. pylori infection in adults

From: Physicians’ adherence to management guidelines for H. pylori infection and gastroesophageal reflux disease: a cross-sectional study

 Number/Total (percent)Weighted Percent*
Refer forH. pyloridiagnosis in the case of **
 Suspected duodenal or gastric ulcer153/180 (85%)84%
 First degree relatives with gastric cancer83/180 (46%)47%
 Unexplained iron deficiency anemia109/180 (61%)59%
 Before starting long-term use of aspirin or NSAIDs in patients with a history of peptic disease82/180 (46%)44%
Prescription of first-line therapy
 Triple therapy with PPIs/clarithromycin/amoxicillin or metronidazole141/171 (83%)82%
 Quadruple therapy based on Bismuth15/171 (9%)9%
 Quadruple therapy non-Bismuth7/171 (4%)4%
 Refer to gastroenterologist2/171 (1%)2%
 Other6/171 (3%)3%
Duration of treatment
 7 days15/171 (9%)8%
 10 days83/171 (48%)51%
 14 days65/171 (38%)36%
 Other8/171 (5%)5%
Follow-up test
 UBT at least 1 month after therapy95/171 (56%)57%
 Refer to specialist in gastroenterology4/171 (2%)1%
 Stool antigen detection EIA at least 1 month after therapy2/171 (1%)1%
 Serology at least 1 month after therapy5/171 (3%)2%
 Do not refer to a test if symptoms resolve58/171 (34%)34%
 Other7/171 (4%)5%
In case of treatment failure
 Refer to a specialist in gastroenterology74/171 (43%)45%
 Do not refer to a test if symptoms resolve43/171 (25%)23%
 Recommend the same treatment for a longer duration5/171 (3%)2%
 Recommend a different treatment49/171 (29%)30%
  1. * Percentage obtained by inverse probability weighting
  2. ** Physicians who answered “always” or “usually”
  3. EIA: Enzyme immunoassay; NSAID: non-steroidal anti-inflammatory drugs; PPIs: proton pump inhibitors; UBT: Urea breath test